CAS 51551-41-8
:3-chloro-5-(3-chloropropyl)-10,11-dihydro-5H-dibenzo[b,f]azepine
Description:
3-Chloro-5-(3-chloropropyl)-10,11-dihydro-5H-dibenzo[b,f]azepine is a chemical compound characterized by its complex bicyclic structure, which includes a dibenzoazepine core. This compound features a chlorine atom at the 3-position and a 3-chloropropyl substituent at the 5-position, contributing to its unique reactivity and potential biological activity. The presence of the chlorine atoms may influence its lipophilicity and interaction with biological targets. The dihydro form indicates that the compound has two hydrogen atoms added to the double bonds in the azepine ring, which can affect its stability and reactivity. This compound may exhibit pharmacological properties, making it of interest in medicinal chemistry, particularly in the development of therapeutic agents. Its CAS number, 51551-41-8, allows for easy identification in chemical databases. As with many organic compounds, its solubility, melting point, and other physical properties would depend on the specific conditions under which they are measured.
Formula:C17H17Cl2N
InChI:InChI=1/C17H17Cl2N/c18-10-3-11-20-16-5-2-1-4-13(16)6-7-14-8-9-15(19)12-17(14)20/h1-2,4-5,8-9,12H,3,6-7,10-11H2
SMILES:c1ccc2c(c1)CCc1ccc(cc1N2CCCCl)Cl
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.
3-Chloro-5-(3-chloropropyl)-10,11-dihydro-5H-dibenz[b,f]azepine
CAS:Controlled Product<p>Applications Clomipramine intermediate as analgesic, antidiabetic and antiinflammatory agent.<br>References Nakanishi, et al.: J. Med. Chem., 13, 644 (1970),<br></p>Formula:C17H17Cl2NPurity:>90%Color and Shape:NeatMolecular weight:306.233-Chloro-5-(3-chloropropyl)-10,11-dihydro-5H-dibenz[b,f]azepine
CAS:<p>Please enquire for more information about 3-Chloro-5-(3-chloropropyl)-10,11-dihydro-5H-dibenz[b,f]azepine including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formula:C17H17Cl2NPurity:90%MinMolecular weight:306.23 g/mol

